Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS IN BRIEF
March 15, 2004
- BUSINESS NEWS IN BRIEF
March 15, 2004
- 1st 3 Qtrs Business Results
March 15, 2004
- Nihon Medi-Physics' 123I-iomazenil Recommended for Approval
March 15, 2004
- Clinical Evaluation GL for Anti-RA, Other Drugs to Be Prepared by PFSB: SJP Meeting
March 15, 2004
- Novo Nordisk to Introduce New MR Training System in April
March 8, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 8, 2004
- MEDICAL DEVICE NEWS IN BRIEF
March 8, 2004
- Major Purchasers Taking Advantage of Consumption Tax Labeling Change
March 8, 2004
- Aiming to Strengthen R&D Capability, Independent Sales Forces Abroad: Yamanouchi, Fujisawa
March 8, 2004
- OTC NEWS IN BRIEF
March 8, 2004
- Allegra, Alesion Are Doctors' 1st Choice Prescriptions for Pollinosis: PJ, So-net M3 Survey
March 8, 2004
- WORLD NEWS IN BREIF
March 8, 2004
- Pharma Sales to Fall Short of Forecast in FY2003: Ajinomoto
March 8, 2004
- Daiichi to Establish R&D Subsidiary in the US Aimed at FDA Applications
March 8, 2004
- The Economist Conferences
March 8, 2004
- Taiyo to Expand "Total Contract Manufacturing" Business
March 8, 2004
- BUSINESS NEWS IN BRIEF
March 8, 2004
- PFSB to Revise GL on Information Disclosure
March 8, 2004
- REGULATORY NEWS IN BRIEF
March 8, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…